Topical Collection on Pathogenesis of Type 1 Diabetes
In this topical collection (46 articles)
-
Pathogenesis of Type 1 Diabetes (A Pugliese, Section Editor)
Interleukin-7 and Type 1 Diabetes
Paolo Monti, Ezio Bonifacio Article:518 -
Pharmacologic Treatment of Type 2 Diabetes (A Vella, Section Editor)
Use of Metformin in Diseases of Aging
John M. Miles, Andrew D. Rule, Barry A. Borlaug Article:490 -
Pharmacologic Treatment of Type 2 Diabetes (A Vella, Section Editor)
Cardiovascular Actions of GLP-1 and Incretin-Based Pharmacotherapy
Angelo Avogaro, Saula Vigili de Kreutzenberg, Gian Paolo Fadini Article:483 -
Pharmacologic Treatment of Type 2 Diabetes (A Vella, Section Editor)
Bile Acid Sequestrants: Glucose-Lowering Mechanisms and Efficacy in Type 2 Diabetes
Morten Hansen, David P. Sonne, Filip K. Knop Article:482 -
Pharmacologic Treatment of Type 2 Diabetes (A Vella, Section Editor)
The Sum of Many Parts: Potential Mechanisms for Improvement in Glucose Homeostasis After Bariatric Surgery
Kim T. Nguyen, Judith Korner Article:481 -
Pharmacologic Treatment of Type 2 Diabetes (A Vella, Section Editor)
Systematic Reviews to Ascertain the Safety of Diabetes Medications
Michael R. Gionfriddo, Oscar L. Morey-Vargas, Juan P. Brito… Article:478 -
Pharmacologic Treatment of Type 2 Diabetes (A Vella, Section Editor)
Sulfonylureas: A New Look at Old Therapy
Peter M. Thulé, Guillermo Umpierrez Article:473 -
Pharmacologic Treatment of Type 2 Diabetes (A Vella, Section Editor)
The Potential of Cell-based Therapy for Diabetes and Diabetes-related Vascular Complications
Aaron Liew, Timothy O’Brien Article:469 -
Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors)
Technological Advancements in the Management of Type 2 Diabetes
Abigail Kennedy Grant, Lauren Golden Article:163 -
Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors)
Pharmacologic Randomized Clinical Trials in Prevention of Type 2 Diabetes
William C. Knowler, Jill P. Crandall Article:154 -
Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors)
Thiazolidinediones: the Forgotten Diabetes Medications
Harold E. Lebovitz Article:151 -
Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors)
Adverse Effects of Glycemia-Lowering Medications in Type 2 Diabetes
Laleh Razavi-Nematollahi, Faramarz Ismail-Beigi Article:132 -
Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors)
Current Therapies That Modify Glucagon Secretion: What Is the Therapeutic Effect of Such Modifications?
Magnus F. Grøndahl, Damien J. Keating, Tina Vilsbøll… Article:128 -
Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors)
A Plethora of GLP-1 Agonists: Decisions About What to Use and When
Susan L. Samson, Alan J. Garber Article:120 -
Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors)
Pharmacological Management of Gestational Diabetes Mellitus
Riki Bergel, Eran Hadar, Yoel Toledano, Moshe Hod Article:118 -
Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors)
Heart Failure: a Major Cardiovascular Complication of Diabetes Mellitus
Gül Bahtiyar, David Gutterman, Harold Lebovitz Article:116 -
Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors)
Personalized Management of Type 2 Diabetes
Patricia R. Peter, Beatrice C. Lupsa Article:115 -
Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors)
Keeping Up with the Diabetes Technology: 2016 Endocrine Society Guidelines of Insulin Pump Therapy and Continuous Glucose Monitor Management of Diabetes
Alfonso Galderisi, Elise Schlissel, Eda Cengiz Article:111 -
Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors)
Type 2 Diabetes Mellitus, Insulin Resistance, and Vitamin D
Alan Sacerdote, Paulomi Dave, Vladimir Lokshin, Gül Bahtiyar Article:101 -
Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors)
What Are We Learning from the FDA-Mandated Cardiovascular Outcome Studies for New Pharmacological Antidiabetic Agents?
Dragana Lovre, Wynn Htun, Carly Carrion, Vivian A. Fonseca Article:94
Continue reading...
To view the rest of this content please follow the download PDF link above.